Genetics

Targeting the Right Treatment for the Right Patient in ALK Therapy Selection for Non-Small-Cell Lung Cancer Carlsbad, CA. – Feb 13, 2013 – Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced today that its GenASIs Scan...

Visit our booth (#237) at the Molecular Med-Tri-Con conference on Feb 11-13 to learn about PerkinElmer’s comprehensive range of digital and molecular pathology solutions for imaging and quantifying biomarkers in tissue sections.  At the...

IBM Research aims to build a nanoscale DNA sequencer, which if succesful could improve throughput and reduce cost to $100–$1,000 per genome sequenced. The scientists’ technique will analyze genetic code by passing DNA strands through...

NIH continues to do its part of allocating funding from stimulus money...Some of it seems excessive.  Nearly $8 million to bail out a drug company?  And only $22 million to IUPUI out of $5 billion?  Good to see investment in...

Check out Dark Daily's story on FISH-Based Test to Diagnose Melanoma is Goal of Neogenomics. Abbott Laboratories will supply Neogenomics with proprietary probes to develop and commercialize its own FISH-based test for...

Integration of MIRAX Virtual Slide Scanner from Carl Zeiss into Bruker’s MALDI Molecular Imager™ Enables Non-Targeted Molecular Histology -- Combined Solution to be Introduced at German Pathology Society (DGP) Meeting in June 2009 BREMEN,...